Navigation Links
Researchers receive NIH grant to study predictors and outcomes of autoimmune lung disease
Date:2/23/2010

CINCINNATIResearchers at the University of Cincinnati (UC) Interstitial Lung Disease Center have received a grant from the National Heart, Lung and Blood Institute to study ways ILD first appears in certain patient groups with autoimmune diseases and how to more efficiently diagnose and treat it.

ILD is a group of diseases that affect the tissues of the lungs instead of the airways, like asthma and emphysema do. It causes scarring of the lungs, is more difficult to diagnosis and treat than other kinds of lung diseases and is often fatal.

Brent Kinder, MD, director of the ILD Center and UC Health pulmonologist, says the $715,000 K23 clinical research grant will be used to find ways for physicians to more accurately diagnose and manage ILD patients who first present with undifferentiated connective tissue disease.

This disease is a chronic inflammatory autoimmune disease that affects multiple organ systems but is not developed enough for physicians to easily recognize and categorize.

Autoimmune diseases occur when the body produces abnormal cells that turn on the body and attack major organs and tissues. Connective tissue diseases include lupus, scleroderma, polymyositis, vasculitis, rheumatoid arthritis and Sjogren's syndrome.

"This study will look at the clinical course of the disease in patients with autoimmune ILDusing biomarkers and medical recordsand will help physicians determine which treatments tend to be the most beneficial," he says. "This research focuses on associating patient and disease characteristics with the best outcomes."

Kinder says that although 30 to 40 percent of all ILD patients present with connective tissue disease, there is often a delay in diagnosis because of the nonspecific nature and varied time course in development of autoimmune diseases.

"If patients don't meet criteria neatly, their illness is often treated as idiopathic, or as having an unknown cause," he continues. "This can lead to a delayed diagnosis and allows further progression of the illness before appropriate treatment is applied. We hope to discover better ways of identifying specific groups of ILD patients who present with connective tissue diseases, find out why this occurs and raise awareness for rheumatologists and pulmonologists, whose patients may be at risk for developing ILD."


'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. Husbands hostile, anti-social behaviors increase wives symptoms of depression, researchers find
2. Penn researchers find genetic link to leukemias with an unknown origin
3. Researchers discover second protective role for tumor-suppressor
4. Researchers chart genomic map spanning over 2 dozen cancers
5. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
6. Clemson researchers develop hands-free texting application
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
9. Researchers create drug to keep tumor growth switched off
10. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
11. Researchers discover new way to kill pediatric brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)...  ValGenesis Inc., the global leader in Enterprise ... announce the appointment of Dr. Ajaz Hussain ... Directors and Chairman of Advisory Board beginning September ... to manage their entire validation lifecycle process electronically ... process. Furthermore, ValGenesis VLMS enables rigorous compliance, helps ...
Breaking Medicine Technology: